TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

1.80$ +5.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

Karyopharm Therapeutics Inc (KPTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -75 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow KPTI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-51 -94 -84 -74 -159 -191 -160 -107 -150 -93 -127 -75
0.3 0.6 0.7 0.7 0.7 1.0 1.0 0.8 0.6 0.5 0.3 -0.1
14 17 22 20 17 15 24 30 35 22 18 14
14 17 22 20 17 15 24 37 35
9.7 4.0 1.0 33 -0.2 -13 1.4 -23 -20 31 -0.3 28
2.8 1.4 0.1 0.1 2.4 0.2 0.1 5.7 0.1 0.0 0.1 0.0
-67 -91 25 17 -108 78 -54 142 -104 7.9 95 43
0.0 0.0 0.0 0.0
113 0.6 0.6 0.9 3.5 4.5 10 3.7 4.0 111
167 167 167 167 0.0 0.0 83 27
113 93 51 76 316 124 172 74 194 1.1 42 30
-5.4 -92 -8.7 19 49 12 -42 108 -61 -84 9.6 -1.9
-54 -95 -84 -74 -161 -191 -160 -113 -150 -93 -128 -75

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?